Award
National Institute on Aging 4R01AG081989-04
A smart cell drug (SmaCD) delivery platform for mobile, targetable, and self-regulated combination therapy: a model project to rescue antibodies from Alzheimer's disease (AD) clinical trial failures
Recipient
National Institute on Aging (NIA), part of NIH (National Institutes of Health)
Award Amount
$914,477.00
Ceiling
$914,477.00
Awarded
July 28, 2025
Identifier
4R01AG081989-04
Research grant awarded by NIH/NIA to develop a smart cell drug delivery platform for Alzheimer's disease, with a total funding of $914,477 for the period July 2025 to June 2027.
Description
This is a research grant award for a project focused on developing a smart cell-based drug delivery system for Alzheimer's disease, supporting multiple drugs and targeting brain regions affected by AD. The project involves initial testing in human and mouse cells, followed by in vivo validation in transgenic mouse models. The funding is provided by the NIH/NIA with a total award amount of $914,477, spanning from July 2025 to June 2027.